TrialLipids in health and disease2015

Influence of metabolic syndrome factors and insulin resistance on the efficacy of ezetimibe/simvastatin and atorvastatin in patients with metabolic syndrome and atherosclerotic coronary heart disease risk.

Jeffrey B Rosen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.